teleocidin b-4 has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Hiai, H; Iijima, S; Kaneshima, H; Nishizuka, Y; Sugimura, T | 1 |
| Fehr, T; Gavériaux, C; Loor, F; Montecino-Rodriguez, E; Sanglier, JJ | 1 |
2 other study(ies) available for teleocidin b-4 and Experimental Leukemia
| Article | Year |
|---|---|
Teleocidin-induced modulation of growth and cell interaction in microenvironment-dependent mouse leukemias.
Topics: Alkaloids; Animals; Antibodies, Monoclonal; Antigens, Ly; Carcinogens; Cocarcinogenesis; Leukemia, Experimental; Lyngbya Toxins; Mice; Mice, Inbred AKR; Tetradecanoylphorbol Acetate; Thymus Gland | 1983 |
Protein kinase C activators of the teleocidin family decrease the IgE-binding capacity of rat basophilic leukemia cells.
Topics: Animals; Basophils; Cell Division; Cell Line; Enzyme Activation; Immunoglobulin E; Leukemia, Experimental; Lyngbya Toxins; Protein Binding; Protein Kinase C; Rats; Receptors, Fc; Serotonin; Tumor Cells, Cultured | 1988 |